{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:47:44Z","timestamp":1793468864175,"version":"4.5.0"},"reference-count":39,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["UEG Journal"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aims<\/jats:title>\n                    <jats:p>Faecal microbiota transplantation (FMT) is increasingly used. However, no systematic approach exists to assess infectious risks after FMT, leading to underreporting. We evaluated infectious complications at the Netherlands Donor Feces Bank (NDFB) and proposed a structured biovigilance approach aligned with the EU Regulation on Substances of Human Origin (SoHO).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a prospective observational cohort study of all patients receiving frozen donor faecal suspensions from the NDFB (May 2016\u2013December 2023) for recurrent\n                      <jats:italic>Clostridioides difficile<\/jats:italic>\n                      infection (rCDI) or via an extended access programme (EAP) for non\u2010CDI indications. (Serious) adverse events ((S)AEs) were reported by physicians and recorded at 3\u00a0weeks, 3\u00a0months, and 6\u00a0months. Serious adverse reactions (SARs) were defined as SAEs probably or definitely related to FMT.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We included 290 rCDI patients (322 FMTs) and 35 EAP patients (75 FMTs). FMT efficacy was favourable overall: 92% of rCDI patients remained free of rCDI within 8\u00a0weeks, and 49% of EAP patients achieved at least a partial response. Sixty\u2010one per cent of rCDI patients and 34% of EAP patients had mild gastrointestinal AEs. AE incidences were comparable across groups (rCDI: 5.1 vs. EAP: 4.4 per 100 patient\u2013weeks). SAEs were more frequent in EAP patients (0.66 vs. 0.28 per patient), reflecting higher immunosuppression and comorbidity. FMT\u2010attributable SARs occurred after 6 of 322 FMTs (1.9%) in the rCDI group and after 3 of 75 FMTs (4.0%) in the EAP group. Two donor\u2013derived\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      infections in EAP patients with predisposing conditions were confirmed, consistent with early donor\u2013strain colonisation rather than a direct FMT effect. Most SAEs were unrelated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this 7\u2010year cohort, donor\u2010derived infections were rare but present, particularly in non\u2010CDI patients with substantial comorbidity, whereas overall safety remained favourable. A SoHO\u2010compliant biovigilance protocol incorporating microbiological investigation and donor\/sample traceability is essential for the safe clinical use of FMT and faecal microbiota products.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ueg2.70239","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T10:12:47Z","timestamp":1781259167000},"source":"Crossref","is-referenced-by-count":1,"title":["Biovigilance in Faecal Microbiota Transplantation: 7\u2010Year Cohort Study and Framework for Microbiological Assessments of Infectious Adverse Events"],"prefix":"10.1002","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4437-6259","authenticated-orcid":false,"given":"V. O.","family":"Chernova","sequence":"first","affiliation":[{"name":"Netherlands Donor Feces Bank Leiden University Center of Infectious Diseases\u2010 Medical Microbiology &amp; Infection Prevention (LUCID\u2010MMIP) Leiden University Medical Center (LUMC)  Leiden the Netherlands"},{"name":"Department of Neurology LUMC  Leiden the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"van Prehn","sequence":"additional","affiliation":[{"name":"Netherlands Donor Feces Bank Leiden University Center of Infectious Diseases\u2010 Medical Microbiology &amp; Infection Prevention (LUCID\u2010MMIP) Leiden University Medical Center (LUMC)  Leiden the Netherlands"},{"name":"Center for Microbiota Analyses and Therapeutics Leiden University Center for Infectious Diseases\u2010Research (LUCID\u2010R) LUMC  Leiden the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Groenewegen","sequence":"additional","affiliation":[{"name":"Netherlands Donor Feces Bank Leiden University Center of Infectious Diseases\u2010 Medical Microbiology &amp; Infection Prevention (LUCID\u2010MMIP) Leiden University Medical Center (LUMC)  Leiden the Netherlands"},{"name":"Department of Gastroenterology and Hepatology LUMC  Leiden the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"van Lingen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology LUMC  Leiden the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. J.","family":"Kuijper","sequence":"additional","affiliation":[{"name":"Center for Microbiota Analyses and Therapeutics Leiden University Center for Infectious Diseases\u2010Research (LUCID\u2010R) LUMC  Leiden the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. M. C.","family":"Lambregts","sequence":"additional","affiliation":[{"name":"Leiden University Center for Infectious Diseases Leiden University Medical Center  Leiden the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"van Nood","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, and Department of Medical Microbiology and Infectious Diseases Erasmus Medical Center  Rotterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Hematology University Medical Center Groningen (UMCG) University of Groningen  Groningen the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. D.","family":"Hazenberg","sequence":"additional","affiliation":[{"name":"Department of Hematology Amsterdam University Medical Centers University of Amsterdam  Amsterdam the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. J.","family":"Keller","sequence":"additional","affiliation":[{"name":"Netherlands Donor Feces Bank Leiden University Center of Infectious Diseases\u2010 Medical Microbiology &amp; Infection Prevention (LUCID\u2010MMIP) Leiden University Medical Center (LUMC)  Leiden the Netherlands"},{"name":"Department of Gastroenterology and Hepatology LUMC  Leiden the Netherlands"},{"name":"Department of Gastroenterology Haaglanden Medical Center  The Hague the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. M.","family":"Terveer","sequence":"additional","affiliation":[{"name":"Netherlands Donor Feces Bank Leiden University Center of Infectious Diseases\u2010 Medical Microbiology &amp; Infection Prevention (LUCID\u2010MMIP) Leiden University Medical Center (LUMC)  Leiden the Netherlands"},{"name":"Center for Microbiota Analyses and Therapeutics Leiden University Center for Infectious Diseases\u2010Research (LUCID\u2010R) LUMC  Leiden the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"e_1_2_14_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1205037"},{"key":"e_1_2_14_3_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev\u2010med\u2010111717\u2010122956"},{"key":"e_1_2_14_4_1","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1394379"},{"key":"e_1_2_14_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16148"},{"key":"e_1_2_14_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2019.04.008"},{"key":"e_1_2_14_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000001281"},{"key":"e_1_2_14_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.10.002"},{"key":"e_1_2_14_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ247"},{"key":"e_1_2_14_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.04.003"},{"key":"e_1_2_14_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910437"},{"key":"e_1_2_14_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl\u20102019\u2010319548"},{"key":"e_1_2_14_13_1","volume-title":"Guide to the Quality and Safety of Tissues and Cells for Human Application","author":"(EDQM), European Directorate for the Quality of Medicines & HealthCare","year":"2022"},{"key":"e_1_2_14_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl\u20102025\u2010336532"},{"key":"e_1_2_14_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.05.015"},{"key":"e_1_2_14_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/2050640620957765"},{"key":"e_1_2_14_17_1","unstructured":"uropean Directorate for the Quality of Medicines & Healthcare: Guide to the Quality and Safety of Tissues and Cells for Human Application.2022."},{"key":"e_1_2_14_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.09.038"},{"key":"e_1_2_14_19_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.05.008"},{"key":"e_1_2_14_20_1","unstructured":"Common Terminology Criteria for Adverse Events (Ctcae) Version 5.0.2017."},{"key":"e_1_2_14_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac324"},{"key":"e_1_2_14_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13099\u2010022\u201000491\u20103"},{"key":"e_1_2_14_23_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161174"},{"key":"e_1_2_14_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.09.060"},{"key":"e_1_2_14_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021005110"},{"key":"e_1_2_14_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.257"},{"key":"e_1_2_14_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0016\u20105085(12)61356\u20100"},{"key":"e_1_2_14_28_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.01.010"},{"key":"e_1_2_14_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2423026"},{"key":"e_1_2_14_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40168\u2010020\u20100792\u20105"},{"key":"e_1_2_14_31_1","doi-asserted-by":"publisher","DOI":"10.1177\/20406223211028790"},{"key":"e_1_2_14_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl\u20102014\u2010307240"},{"key":"e_1_2_14_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1993584"},{"key":"e_1_2_14_34_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.04.001"},{"key":"e_1_2_14_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(17)30182\u20104"},{"key":"e_1_2_14_36_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.09.038"},{"key":"e_1_2_14_37_1","doi-asserted-by":"publisher","DOI":"10.26355\/mhd_202311_954"},{"key":"e_1_2_14_38_1","volume-title":"Regulation (Eu) 2024\/1938 of the European Parliament and of the Council of 13 June 2024 on Standards of Quality and Safety for Substances of Human Origin Intended for Human Application and Repealing Directives 2002\/98\/Ec and 2004\/23","year":"2024"},{"key":"e_1_2_14_39_1","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2025.2493901"},{"key":"e_1_2_14_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473\u20103099(20)30473\u20104"}],"container-title":["United European Gastroenterology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ueg2.70239","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ueg2.70239","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ueg2.70239","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:27:29Z","timestamp":1785371249000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ueg2.70239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1002\/ueg2.70239"],"URL":"https:\/\/doi.org\/10.1002\/ueg2.70239","archive":["Portico"],"relation":{},"ISSN":["2050-6406","2050-6414"],"issn-type":[{"value":"2050-6406","type":"print"},{"value":"2050-6414","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"article-number":"e70239"}}